Bank of New York Mellon’s DNA X Inc SONM Stock Holding History
Bought
Maintained
Sold
Other funds holding SONM
SA
TSS
FFA
XT
Bank of New York Mellon's SONM Position: Q2 2024 in Review
Bank of New York Mellon sold out of DNA X Inc (SONM) in Q2 2024, closing a stake of 1,121 shares — an estimated $123K sold.
Bank of New York Mellon first reported a position in SONM in Q4 2019 and held it in 15 quarters. The position peaked at $248K in Q2 2023. 15 funds tracked by Wall St. Rank hold SONM as of Q2 2024.
- Bank of New York Mellon reported no remaining DNA X Inc position as of Q2 2024 after selling out during the quarter.
- Bank of New York Mellon sold 1,121 DNA X Inc shares in Q2 2024, an estimated $123K.
- Bank of New York Mellon first reported a position in DNA X Inc in Q4 2019 and held it in 15 quarters.
- Bank of New York Mellon's DNA X Inc position peaked at $248K in Q2 2023.
- 15 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2024.
Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.